Business
Press Release Apr 24 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 24, 2023, titled "Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules, 0.5 g and 1 g".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 24, 2023, titled \"Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules, 0.5 g and 1 g\". View Attachment","length":353,"tagName":"div"}]